Company Directory

Company Directory

Company Directory - Johnson & Johnson

Company Details - Johnson & Johnson

Johnson & Johnson Logo

Johnson & Johnson

Website

New Brunswick, United States

NYSE: JNJ 

Johnson & Johnson is a multinational healthcare company that develops and manufactures medical devices, pharmaceuticals, and consumer packaged goods. The company focuses on driving innovation in health and well‐being globally.

CCI Score

CCI Score: Johnson & Johnson

15.11

Latest Event

J&J Political Contributions and Lobbying Profile

OpenSecrets data indicates that Johnson & Johnson spent $1,759,932 in campaign contributions and $8,250,000 on lobbying during the 2024 cycle, raising concerns about corporate influence in political decisions.

Take Action

So what can you do? Support J&J by shopping, spreading the word, or offering your support.

Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

SABOTEUR

Johnson & Johnson is currently rated as a Saboteur.

+10 to +24 CCI Score
Companies in this bracket take more subtle actions to undermine authoritarian practices. They might implement internal policies or support reforms that quietly weaken oppressive systems, contributing to change in less overt ways.

Latest Events

  • J&J Political Contributions and Lobbying Profile Logo
    APR
    24
    2025

    OpenSecrets data indicates that Johnson & Johnson spent $1,759,932 in campaign contributions and $8,250,000 on lobbying during the 2024 cycle, raising concerns about corporate influence in political decisions.

  • -20

    Political Contributions and Lobbying Efforts

    June 6

    The OpenSecrets profile reveals significant financial involvement in political contributions and lobbying. This level of expenditure can be seen as an exertion of corporate influence over the political landscape, potentially undermining democratic accountability, particularly in an era when corporate actions can sway policy towards prioritizing profits over social and worker rights.

    Johnson & Johnson Profile: Summary - OpenSecrets

  • J&J Invests $55B in Domestic Manufacturing Amid Tariff Threats Logo
    MAR
    21
    2025

    Johnson & Johnson announced an investment of over $55 billion to build four new manufacturing plants in the United States over the next four years, including a groundbreaking at its Wilson, North Carolina site. The expansion, announced amid looming tariff threats from the Trump administration, is expected to create thousands of construction and permanent jobs while reinforcing the company's domestic production capabilities.

  • +40

    Economic and Structural Influence

    June 6

    The planned domestic expansion represents a proactive initiative to bolster U.S. manufacturing and job creation in response to coercive tariff threats. By investing heavily in local infrastructure, J&J not only mitigates risks from authoritarian trade pressures but also contributes positively to the domestic economy and labor market, aligning with anti-fascist and pro-worker objectives.

    J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

  • Johnson & Johnson Announces $55 Billion U.S. Investment Logo
    MAR
    21
    2025

    Johnson & Johnson announced plans to invest over $55 billion in the United States over the next four years, including the construction of four new manufacturing plants in North Carolina and expansion of existing facilities, which is expected to significantly boost U.S. job creation and economic activity.

  • +70

    Economic and Structural Influence

    June 6

    This major domestic investment promotes economic and structural resilience by creating new jobs and expanding U.S. manufacturing and R&D capabilities. By strengthening local industry and workforce, the initiative supports economic empowerment and counters tendencies toward authoritarian economic centralization.

    Johnson & Johnson plans $55 billion in U.S. investments

  • J&J Expands U.S. Manufacturing Amid Tariff Pressure Logo
    MAR
    21
    2025

    Johnson & Johnson announced a major investment of over $55 billion to build four new manufacturing plants in the U.S. over the next four years, a decision driven by looming tariff threats from the Trump administration. The expansion is expected to boost domestic job creation and reinforce the company’s U.S. operational footprint.

  • +50

    Business Practices and Ethical Responsibility

    June 6

    The significant domestic investment and expansion of manufacturing facilities indicates a commitment to boosting local economies and creating jobs. This move supports progressive labor and economic practices by reinforcing domestic production in the face of protectionist tariff threats, which aligns with responsible business practices.

    J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

  • +30

    Economic and Structural Influence

    June 6

    The expansion strengthens domestic economic infrastructure and reduces reliance on foreign manufacturing, thereby bolstering national economic resilience. This action aligns with progressive economic policies that favor local job creation and counteract authoritarian trade pressures.

    J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

  • J&J PAC Donations in 2023-2024 Elections Logo
    OCT
    28
    2024

    Johnson & Johnson’s PAC donated nearly $500,000 to political campaigns during 2023 and 2024, with a slight Republican lean, as reported by PharmaVoice. The company's CEO, Joaquin Duato, did not make individual contributions, relying on the PAC to fund political activities.

  • -40

    Political Contributions and Lobbying Efforts

    June 6

    The article highlights that Johnson & Johnson’s PAC has donated nearly $500,000 over the past two years, with a slight tilt toward Republican candidates. From an anti-fascist perspective, support for candidates leaning more conservative is concerning as it may bolster policies aligned with authoritarian tendencies.

    Where Big Pharma’s campaign cash is flowing in this election

  • Johnson & Johnson Political Engagement Policy Logo
    OCT
    12
    2023

    Johnson & Johnson's governance page on political engagement details its process for making transparent, compliance-driven political contributions. The company utilizes an employee-funded Political Action Committee (J&J PAC) and follows rigorous legal guidelines when supporting candidates whose platforms emphasize medical innovation and broad access to quality healthcare.

  • +20

    Political Contributions and Lobbying Efforts

    June 6

    Johnson & Johnson conducts its political contributions via an employee-funded PAC and adheres strictly to legal requirements. The company supports candidates based on their commitment to medical innovation and accessible healthcare, which aligns with progressive, anti-authoritarian and inclusive values. This transparent approach to political engagement reflects a commitment to diverse viewpoints and responsible corporate behavior.

    Governance - Political engagement

  • Congressional Inquiry into Censorship Collusion Logo
    JUL
    18
    2023

    House Judiciary Committee Chairman Jim Jordan sent letters to CEOs of major pharmaceutical companies—including Johnson & Johnson—to demand documents related to potential collusion with the executive branch in moderating and censoring online content, raising questions about the role of these companies in the censorship regime.

  • -40

    Executive Political Engagement

    June 6

    The inquiry targets Johnson & Johnson’s executive leadership (CEO Joaquin Duato) for possible involvement in efforts that may suppress free speech through coordination with the executive branch. Such engagement raises concerns about alignment with authoritarian practices in political engagement.

    Jordan Seeks Documents from Big Pharma in Censorship Probe

  • -35

    Media Influence and Propaganda

    June 6

    The company's potential involvement in discussions and actions that contributed to the moderation and suppression of content online indicates a role in a censorship regime that undermines civil liberties and democratic discourse.

    Jordan Seeks Documents from Big Pharma in Censorship Probe

  • J&J Enhances Palm Oil Supply Chain Ethics Logo
    DEC
    08
    2020

    In response to reports of human rights abuses, Johnson & Johnson reiterated its commitment to ethical sourcing by enforcing its Responsible Palm Oil Sourcing Criteria, which prohibits forced, bonded or child labor, and by partnering with Earthworm Foundation to ensure supply chain transparency.

  • +70

    Supply Chain Ethics

    June 6

    Johnson & Johnson's response clearly outlines proactive measures to ensure that palm oil used in its products is sourced ethically. The company emphasizes adherence to strict Responsible Palm Oil Sourcing Criteria, which explicitly prohibits forced, bonded or child labor, and respects the rights of all workers. The partnership with Earthworm Foundation further underscores its commitment to transparency and accountability across its supply chain, representing a positive step in upholding human rights and ethical business practices.

    Business & Human Rights Resource Centre

Industries

325412
Pharmaceutical Preparation Manufacturing
325611
Soap and Other Detergent Manufacturing
339112
Surgical and Medical Instrument Manufacturing
424210
Drugs and Druggists' Sundries Merchant Wholesalers
325614
Biological Product (except Diagnostic) Manufacturing